FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns application of Selank peptide for protective effect at general cooling. Described is the use of a peptide of formula Thr-Lys-Pro-Arg-Pro-Gly-Pro (selank) as a tread agent in preventing and/or treating general mammal body cooling in intranasal administration.
EFFECT: reduced lethality and higher active capacity at total body cooling.
1 cl, 1 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF Thr-Lys-Pro-Arg-Pro-Gly-Pro PEPTIDE (SELANK) FOR TOXIC HEPATITIS PREVENTION AND TREATMENT | 2017 |
|
RU2640133C1 |
| APPLICATION OF PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANG) FOR DYSBIOSIS CORRECTION UNDER CHRONIC IMMOBILIZATION STRESS | 2018 |
|
RU2681217C1 |
| APPLICATION OF THR-LYS-PRO-ARG-PRO-GLY-PRO PEPTIDE (SELANK) FOR HEPATOPROTECTIVE IMPACT IN CHRONIC EMOTIONAL-PAIN STRESS | 2016 |
|
RU2629832C1 |
| USE OF PEPTIDE Thr-Lys-Pro-Arg-Pro-Gly-Pro (SELANC) HEPATOPROTECTIVE FOR EXPOSURE IN ACUTE IMMOBILISATION STRESS | 2015 |
|
RU2582963C1 |
| AGENT POSSESSING ANTI-COAGULATING, ANTI-THROMBOCYTIC, ANTI-THROMBOSIS, FIBRIN-DEPOLYMERIZING AND FIBRINOLYTIC ACTIVITY | 2005 |
|
RU2290195C1 |
| ANXIOLYTIC AGENT AND PHARMACEUTICAL COMPOSITION WITH ANXIOLYTIC EFFECT | 1999 |
|
RU2155065C1 |
| METHOD FOR PREVENTING AND TREATING ULCERS OF GASTRO-INTESTINAL TRACT | 2003 |
|
RU2252779C1 |
| ADMINISTRATION OF Arg-Pro-Gly-Pro PEPTIDE AS ANTIVIRAL AGENT FOR ANIMALS | 2009 |
|
RU2414235C1 |
| APPLICATION OF THE HIS-PHE-ARG-TRP-PRO-GLY-PRO PEPTIDE FOR THE PREVENTION OF DYSBIOSIS IN CHRONIC IMMOBILIZATION STRESS | 2021 |
|
RU2770583C1 |
| USE OF THE PEPTIDE GLY-HIS-LYS-PRO-GLY-PRO TO ACHIEVE AN ANTIDEPRESSANT EFFECT | 2020 |
|
RU2747224C1 |
